We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$20.1B
AUM Growth
+$3.5B
Cap. Flow
+$2.5B
Cap. Flow %
12.41%
Top 10 Hldgs %
33.13%
Holding
257
New
120
Increased
40
Reduced
39
Closed
20

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$546M
2
WTW icon
Willis Towers Watson
WTW
+$471M
3
MA icon
Mastercard
MA
+$344M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$240M
5
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$238M

Top Sells

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$301M
2
NYT icon
New York Times
NYT
+$209M
3
V icon
Visa
V
+$194M
4
ELV icon
Elevance Health
ELV
+$145M
5
ABBV icon
AbbVie
ABBV
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 34.84%
2 Financials 13.62%
3 Communication Services 11.15%
4 Technology 9.41%
5 Industrials 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PS
126
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$10.1M 0.05%
+450,000
New +$9.65M
RKTA.U
127
DELISTED
Rocket Internet Growth Opportunities Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RKTA.U
$10M 0.05%
+1,000,000
New +$10M
AAC.U
128
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
$10M 0.05%
+1,000,000
New +$10.2M
CVIIU
129
DELISTED
Churchill Capital Corp VII Units
CVIIU
$9.97M 0.05%
+1,000,000
New +$10.3M
PRDS
130
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$9.96M 0.05%
+1,000,000
New +$10.3M
CRZNU
131
DELISTED
Corazon Capital V838 Monoceros Corp Unit
CRZNU
$9.95M 0.05%
+1,000,000
New +$9.91M
VGII.U
132
DELISTED
Virgin Group Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth
VGII.U
$9.93M 0.05%
+1,000,000
New +$9.95M
FMIVU
133
DELISTED
Forum Merger IV Corporation Unit
FMIVU
$9.9M 0.05%
+1,000,000
New +$9.94M
TWNT.U
134
DELISTED
Tailwind Two Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of
TWNT.U
$9.88M 0.05%
+1,000,000
New +$10M
CAS
135
DELISTED
Cascade Acquisition Corp.
CAS
$9.7M 0.05%
+990,000
New +$10M
TECX
136
Tectonic Therapeutic
TECX
$606M
$9.39M 0.05%
61,667
-4,583
-7% -$745K
ALBO
137
DELISTED
Albireo Pharma Inc
ALBO
$8.81M 0.04%
250,000
– –
SVRA icon
138
Savara
SVRA
$1.19B
$8.58M 0.04%
4,125,877
-326,209
-7% -$558K
ARYD
139
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$8.32M 0.04%
+800,000
New +$8.64M
BOLT icon
140
Bolt Biotherapeutics
BOLT
$7.78M
$8.23M 0.04%
+12,500
New +$8.13M
JWSM.U
141
DELISTED
Jaws Mustang Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
JWSM.U
$8.12M 0.04%
+800,000
New +$8.36M
LVRAU
142
DELISTED
Levere Holdings Corp. Unit
LVRAU
$7.97M 0.04%
+800,000
New +$8.01M
SURF
143
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$7.8M 0.04%
1,000,000
– –
KNTE
144
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$7.79M 0.04%
250,000
– –
RACB
145
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$7.69M 0.04%
+750,000
New +$7.68M
GMIIU
146
DELISTED
Gores Metropoulos II, Inc. Unit
GMIIU
$7.59M 0.04%
+750,000
New +$8M
WPCA.U
147
DELISTED
Warburg Pincus Capital Corporation I-A Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
WPCA.U
$7.56M 0.04%
+750,000
New +$7.58M
RTPYU
148
DELISTED
Reinvent Technology Partners Y Unit
RTPYU
$7.53M 0.04%
+750,000
New +$7.55M
ACTDU
149
DELISTED
ArcLight Clean Transition Corp. II Unit
ACTDU
$7.5M 0.04%
+750,000
New +$7.5M
APGB.U
150
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
$7.49M 0.04%
+750,000
New +$7.72M
4 5
6
7 8

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Farallon Capital Management held 257 positions worth $20.1B, up 21% from $16.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Farallon Capital Management deployed $2.5B of net new capital in Q1 2021, opening 120 new positions and adding to 40 existing holdings. Its largest new stake was Mastercard: 985,920 shares worth $351M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 38% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was New York Times, an estimated $209M trimmed.

  • Farallon Capital Management's largest Q1 2021 buy was Mastercard: 985,920 shares worth $351M.
  • Farallon Capital Management added most to Alexion Pharmaceuticals in Q1 2021, an estimated $546M increase.
  • Farallon Capital Management's biggest Q1 2021 reduction was New York Times, cutting an estimated $209M.
  • Farallon Capital Management fully exited Tiffany & Co. in Q1 2021, selling an estimated $301M.
  • Farallon Capital Management's ten largest holdings make up 33% of its $20.1B portfolio in Q1 2021.
  • Farallon Capital Management opened 120 new positions and closed 20 in Q1 2021.
  • Farallon Capital Management's portfolio value rose 21% quarter-over-quarter to $20.1B.

Based on Farallon Capital Management's 13F filing for Q1 2021, filed 17 May 2021.